C
Catherine M. Tangen
Researcher at Fred Hutchinson Cancer Research Center
Publications - 19
Citations - 3142
Catherine M. Tangen is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 16, co-authored 19 publications receiving 2885 citations. Previous affiliations of Catherine M. Tangen include University of Washington & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans
Abraham A. Ariyo,Mary N. Haan,Catherine M. Tangen,John C. Rutledge,Mary Cushman,Adrian S. Dobs,Curt D. Furberg +6 more
TL;DR: Among elderly Americans, depressive symptoms constitute an independent risk factor for the development of CHD and total mortality.
Journal ArticleDOI
Increased Blood Glucose and Insulin, Body Size, and Incident Colorectal Cancer
Robert E. Schoen,Catherine M. Tangen,Lewis H. Kuller,Gregory L. Burke,Mary Cushman,Russell P. Tracy,Adrian S. Dobs,Peter J. Savage +7 more
TL;DR: These data provide the first direct evidence of an association between elevated visceral adipose tissue level, its associated metabolic effects, and colorectal cancer.
Journal ArticleDOI
Intermittent versus continuous androgen deprivation in prostate cancer.
Maha Hussain,Catherine M. Tangen,Donna L. Berry,Celestia S. Higano,E. David Crawford,Glenn Liu,George Wilding,Stephen Prescott,Subramanian Kanaga Sundaram,Eric J. Small,Nancy A. Dawson,Bryan J. Donnelly,Peter Venner,Ulka N. Vaishampayan,Paul F. Schellhammer,David I. Quinn,Derek Raghavan,Benjamin Ely,Carol M. Moinpour,Nicholas J. Vogelzang,Ian M. Thompson +20 more
TL;DR: In patients with metastatic hormone-sensitive prostate cancer, the confidence interval for survival exceeded the upper boundary for noninferiority, suggesting that the authors cannot rule out a 20% greater risk of death with intermittent therapy than with continuous therapy, but too few events occurred to rule out significant inferiority of intermittent therapy.
Journal ArticleDOI
Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia∗☆
Willem J. Kop,John S. Gottdiener,Catherine M. Tangen,Linda P. Fried,Mary Ann McBurnie,Jeremy D. Walston,Anne B. Newman,Calvin H. Hirsch,Russell P. Tracy +8 more
TL;DR: In this article, the authors examined associations of depressive symptoms with inflammation and coagulation factors in persons aged > 65 years, and found that depression was associated with elevated C-reactive protein (CRP), white blood cell (WBC) count, total platelet count, and albumin.
Journal ArticleDOI
Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction.
TL;DR: Estrogen use was associated with less cognitive decline among ε4-negative women but not ε 4-positive women, and potential mechanisms, including carotid atherosclerosis, by which ε3 may interact with estrogen and cognition warrant further investigation.